Clinical Trials Browser

Phase NA × Lymphoma, Non-Hodgkin × peginterferon alfa-2b × Clear all

NCT00574730 2023-09-14

CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma

Phase NA Completed

Lymphoma, Non-Hodgkin